p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats

被引:8
作者
Kido, A
Tsujiuchi, T
Tsutsumi, M
Takahama, M
Okajima, E
Kobitsu, K
Miyauchi, Y
Mii, Y
Tamai, S
Konishi, Y
机构
[1] NARA MED UNIV,CTR CANC,DEPT ONCOL PATHOL,KASHIHARA,NARA 634,JAPAN
[2] NARA MED UNIV,DEPT ORTHOPED SURG,KASHIHARA,NARA 634,JAPAN
关键词
p53; mutation; mdm2; Ki-ras; transplantable osteosarcomas; rat;
D O I
10.1016/S0304-3835(96)04537-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously, we reported the establishment of two transplantable osteosarcomas, one induced by local application of a carcinogen, 4-hydroxyamino quinoline 1-oxide(4-HAQO), and another which developed spontaneously in rats, and their subdivision into four lines with high and low metastatic potential to the lung. In the present study, mutations of p53 and Ki-ras genes were investigated by PCR and SSCP followed by direct sequencing, and the amplification of the mdm2 gene was assessed by Southern blot analysis. Mutations of p53 in exon 7 were detected in 4-HAQO-induced transplantable osteosarcomas, but not their spontaneous counterparts, irrespective of the metastatic potentials. Direct sequencing revealed a CGC to CAC transition with an amino acid change of Arg to His, at codon 246. Neither Ki-ras mutations nor mdm2 amplification were detected in airy of the transplantable tumors. The results suggest that while p53 mutations occurred during osteosarcoma development by 4-HAQO without mdm2 amplification and Ki-ras mutation does not contribute to osteosarcoma development in rats. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 32 条
[1]   MUTATIONAL ACTIVATION OF RAS GENES IS ABSENT IN PEDIATRIC OSTEOSARCOMA [J].
ANTILLONKLUSSMANN, F ;
GARCIADELGADO, M ;
VILLAELIZAGA, I ;
SIERRASESUMAGA, L .
CANCER GENETICS AND CYTOGENETICS, 1995, 79 (01) :49-53
[2]   AMPLIFICATION OF C-MYC ONCOGENE AND ABSENCE OF C-HA-RAS POINT MUTATION IN HUMAN BONE SARCOMA [J].
BARRIOS, C ;
CASTRESANA, JS ;
RUIZ, J ;
KREICBERGS, A .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1993, 11 (04) :556-563
[3]   THE TUMOR-SUPPRESSOR P53 AND THE ONCOPROTEIN SIMIAN VIRUS-40 T-ANTIGEN BIND TO OVERLAPPING DOMAINS ON THE MDM2 PROTEIN [J].
BROWN, DR ;
DEB, S ;
MUNOZ, RM ;
SUBLER, MA ;
DEB, SP .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (11) :6849-6857
[4]   INTEGRATION AND LOSS OF A SINGLE V-KI-RAS GENE AFFECTS TUMORIGENIC POTENTIAL OF HUMAN OSTEO-SARCOMA CELLS [J].
CARLONI, G ;
VENUAT, AM ;
DAYAGROSJEAN, L ;
NARDEUX, P ;
RHIM, JS ;
AZZARONE, B .
FEBS LETTERS, 1988, 229 (02) :333-339
[5]   4-HYDROXYAMINOQUINOLINE 1-OXIDE METABOLISM AND DNA ADDUCTS IN THE EARLY STAGE OF TUMORIGENESIS IN RATS - COMPARISON OF TARGET ORGAN PANCREAS WITH NONTARGET ORGAN LIVER [J].
DENDA, A ;
MORI, Y ;
YOKOSE, Y ;
UCHIDA, K ;
MURATA, Y ;
MAKINO, T ;
TSUTSUMI, M ;
KONISHI, Y .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 56 (2-3) :125-143
[6]  
GREENBLATT MS, 1994, CANCER RES, V54, P4855
[7]  
HONOKI K, 1993, CANCER RES, V53, P5038
[8]   EXPRESSION OF THE TRANSIN, C-FOS, AND C-JUN GENES IN RAT TRANSPLANTABLE OSTEOSARCOMAS AND MALIGNANT FIBROUS HISTIOCYTOMAS [J].
HONOKI, K ;
TSUTSUMI, M ;
TSUJIUCHI, T ;
KONDOH, S ;
SHIRAIWA, K ;
MIYAUCHI, Y ;
MII, Y ;
TAMAI, S ;
KONISHI, Y ;
BOWDEN, GT .
MOLECULAR CARCINOGENESIS, 1992, 6 (02) :122-128
[9]   CORRELATION BETWEEN LACK OF BONE GLA PROTEIN MESSENGER-RNA EXPRESSION IN RAT TRANSPLANTABLE OSTEOSARCOMAS AND EXPRESSION OF BOTH C-FOS AND C-JUN PROTOONCOGENES [J].
HONOKI, K ;
DOHI, Y ;
TABATA, S ;
MII, Y ;
MIYAUCHI, Y ;
TSUTSUMI, M ;
TSUJIUCHI, T ;
MORISHITA, T ;
MIURA, S ;
MORIYAMA, T ;
TAMAI, S ;
KONISHI, Y .
MOLECULAR CARCINOGENESIS, 1993, 7 (02) :111-115
[10]   AMPLIFICATION OF BOTH C-MYC AND C-RAF-1 ONCOGENES IN A HUMAN OSTEO-SARCOMA [J].
IKEDA, S ;
SUMII, H ;
AKIYAMA, K ;
WATANABE, S ;
ITO, S ;
INOUE, H ;
TAKECHI, H ;
TANABE, G ;
ODA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (01) :6-9